The need for ambulatory emergency oncology: exemplified by the management of immune checkpoint inhibitor toxicity
Cooksley, Tim Klotz, Adam Marshall, E Weaver, J Font, C Lasserson, D
Cooksley, Tim
Klotz, Adam
Marshall, E
Weaver, J
Font, C
Lasserson, D
Citations
Altmetric:
Abstract
Cancer patients seeking emergency care can be vulnerable in increasingly overcrowded Emergency Departments and timely delivery of care is often aspirational rather than reality in many acute care systems. Ambulatory emergency care and its various international models are recognized as contributing to the safety and sustainability of emergency care services. This schema can logically be extended to the emergency oncology setting. The recent proliferation of immune checkpoint inhibitors (ICIs) has led to another opportunity for the management of oncologic complications in the ambulatory emergency care setting. More nuanced risk stratification of currently perceived high-risk toxicities may also afford the opportunity to personalize acute management. Virtual wards, which predominantly provide virtual monitoring only, and hospital at home services, which provide more comprehensive in-person assessment and interventions, may be well suited to supporting care for ICI toxicity alongside hospital-based assessment. Emergency management guidelines for immune-mediated toxicities will increasingly need to be both pragmatic and deliverable, especially as larger numbers of patients will present outside cancer centers. Identifying and modelling those suitable for emergency ambulatory care is integral to achieving this.
Description
Date
2023
Publisher
Collections
Keywords
Type
Article
Citation
Cooksley T, Klotz A, Marshall E, Weaver J, Font C, Lasserson D. The need for ambulatory emergency oncology: exemplified by the management of immune checkpoint inhibitor toxicity. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2023 Oct 25;31(12):653. PubMed PMID: 37878140. Epub 2023/10/25. eng.